School of Nursing, Midwifery, & Health Systems, University College Dublin, Belfield, Dublin, Ireland.
Menopause. 2010 Mar;17(2):344-50. doi: 10.1097/gme.0b013e3181c6b26f.
The aim of this article was to explore women's experiences in biomedical consultations for menopause symptoms, with a particular focus on how hormone therapy (HT) featured during the encounter.
Semistructured interviews were conducted with 39 women, and data were analyzed using a qualitative strategy referred to as Thematic Networks.
Several participants whose menopause started before the period of the HT "scares" described being "put on" HT as a matter of course, even when their symptoms were mild. By contrast, some of those presenting in the more recent time period with what they deemed to be severe symptoms were more likely to describe scenarios whereby they pressured their physicians for an HT prescription. Once on HT, participants were found to be far from passive recipients of a biomedical "treatment" but rather embarked on an active dialogue with themselves about how to manage the distressing aspects of menopause.
Using HT did not tend to spell a transition to biomedical advocacy, despite its reported effectiveness in moderating bodily distresses. Rather, HT tended to retain a tentative status as a temporary relief and not a long-term panacea.
本文旨在探讨女性在更年期症状的生物医学咨询中的体验，特别关注激素治疗 (HT) 在就诊过程中的作用。
对 39 名女性进行了半结构化访谈，并采用一种称为主题网络的定性策略进行数据分析。
一些在 HT“恐慌”时期之前开始更年期的参与者描述说，即使她们的症状较轻，HT 也被理所当然地使用。相比之下，那些在最近时期出现严重症状的参与者更有可能描述他们向医生施压开 HT 处方的情况。一旦开始使用 HT，参与者就不再是生物医学“治疗”的被动接受者，而是开始与自己进行积极的对话，讨论如何管理更年期的不适方面。
尽管 HT 据称可以缓解身体不适，但它并没有导致向生物医学倡导的转变。相反，HT 往往仍然是一种暂时的缓解，而不是长期的灵丹妙药。
